Atlas Trials

Secondary Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for PARP Inhibitors Resistance Patients

Clinical trial NCT06544460 · NOT_YET_RECRUITING

Trial details

NCT number
NCT06544460
Sponsor
Fudan University
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Ovarian Cancer
Start date
2024-08-31
Primary completion
2026-06-30
Enrollment
94

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.